Compare PASG & MLSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PASG | MLSS |
|---|---|---|
| Founded | 2017 | 1989 |
| Country | United States | United States |
| Employees | 27 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.0M | 20.8M |
| IPO Year | 2020 | 1996 |
| Metric | PASG | MLSS |
|---|---|---|
| Price | $7.83 | $0.29 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 1 |
| Target Price | ★ $23.50 | $1.00 |
| AVG Volume (30 Days) | 30.3K | ★ 81.0K |
| Earning Date | 05-26-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $8,629,928.00 |
| Revenue This Year | N/A | $8.95 |
| Revenue Next Year | N/A | $7.51 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.28 | $0.22 |
| 52 Week High | $20.00 | $1.11 |
| Indicator | PASG | MLSS |
|---|---|---|
| Relative Strength Index (RSI) | 37.40 | 50.54 |
| Support Level | $6.71 | $0.24 |
| Resistance Level | $7.72 | $0.31 |
| Average True Range (ATR) | 0.77 | 0.02 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 16.73 | 66.83 |
Passage Bio Inc is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases. Their primary focus is the development and advancement of cutting-edge, one-time gene therapies designed to target critical underlying pathologies in these conditions. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target the critical underlying pathology of neurodegenerative diseases. The pipeline having PBFT02.
Milestone Scientific Inc is a biomedical technology company. The company is engaged in pioneering proprietary, technological systems and solutions for the medical and dental markets. The company develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetics. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. The Company conducts its business through two reportable segments: Dental and Medical.